These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 2677938

  • 21. Social impact of stimulant treatment for hyperactive children.
    Whalen CK, Henker B.
    J Learn Disabil; 1991 Apr; 24(4):231-41. PubMed ID: 1875158
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics and clinical effectiveness of methylphenidate.
    Kimko HC, Cross JT, Abernethy DR.
    Clin Pharmacokinet; 1999 Dec; 37(6):457-70. PubMed ID: 10628897
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.
    Ramtvedt BE, Aabech HS, Sundet K.
    J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):130-9. PubMed ID: 24666268
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) topography predicts treatment response to methylphenidate.
    Sangal RB, Sangal JM.
    Clin Neurophysiol; 2004 Jan; 115(1):188-93. PubMed ID: 14706487
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL.
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [Abstract] [Full Text] [Related]

  • 37. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.
    Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD.
    Pediatrics; 2001 Jun; 107(6):E105. PubMed ID: 11389303
    [Abstract] [Full Text] [Related]

  • 38. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
    Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ.
    J Dev Behav Pediatr; 2006 Feb; 27(1):1-10. PubMed ID: 16511362
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Drug treatment for hyperactive children. Therapeutic guidelines.
    Elia J.
    Drugs; 1993 Nov; 46(5):863-71. PubMed ID: 7507036
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.